Apolipoprotein E Genetic Variation and Its Association With Cognitive Function in Rural-Dwelling Older South Africans by Soo, Cassandra C. et al.
Frontiers in Genetics | www.frontiersin.org 1 October 2021 | Volume 12 | Article 689756
ORIGINAL RESEARCH




Texas A&M University, United States
Reviewed by: 
Karen Anne Mather, 
University of New South Wales, 
Australia 
Margit Burmeister, 
University of Michigan, United States
*Correspondence: 






†These authors have contributed 
equally to this work and share senior 
authorship
Specialty section: 
This article was submitted to 
Behavioral and Psychiatric Genetics, 
a section of the journal 
Frontiers in Genetics
Received: 06 April 2021
Accepted: 18 August 2021
Published: 14 October 2021
Citation:
Soo CC, Farrell MT, Tollman S, 
Berkman L, Nebel A and 
Ramsay M (2021) 
Apolipoprotein E Genetic Variation 
and Its Association With Cognitive 




Apolipoprotein E Genetic Variation 
and Its Association With Cognitive 
Function in Rural-Dwelling Older 
South Africans
Cassandra C. Soo 1,2*, Meagan T. Farrell 3, Stephen Tollman 4, Lisa Berkman 3,5, 
Almut Nebel 1,6† and Michèle Ramsay 1*†
1 Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg, South Africa, 2 Division of Human Genetics, National Health Laboratory Service and School of Pathology, 
Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 3 Harvard Center for Population 
and Development Studies, Harvard University, Cambridge, MA, United States, 4 MRC/Wits Rural Public Health and Health 
Transitions Research Unit, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg, South Africa, 5 Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 
Boston, MA, United States, 6 Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
Apolipoprotein E (APOE) 𝜀4 allele carrier status is well known for its association with an 
increased likelihood of developing Alzheimer’s disease, but its independent role in cognitive 
function is unclear. APOE genetic variation is understudied in African populations; hence, 
this cross-sectional study in a rural South African community examined allele and genotype 
frequencies, and their associations with cognitive function. Cognitive function was 
assessed using two different screening methods to produce a total cognition score and 
four domain-specific cognition scores for verbal episodic memory, executive function, 
language, and visuospatial ability. Cognitive phenotype and APOE genotype data were 
used to determine whether APOE variation was significantly associated with cognitive 
function in this population. Observed allele frequencies for 1776 participants from the 
HAALSI study [age 40–80 years (mean = 56.19); 58.2% female] were 58.1% (𝜀3), 25.4% 
(𝜀4) and 16.5% (𝜀2). Allele distributions were similar to the African super population, but 
different from all non-African super populations from the 1,000 Genomes Project. The 𝜀3 
homozygous genotype was most common (34.9%) and used as the base genotype for 
comparison in regression models. Four models were tested for each of the five cognitive 
phenotypes to explore association of APOE variation with cognitive function. In the first 
model assessing association with all genotypes for all individuals, marginally significant 
associations were observed for 𝜀2 homozygotes where executive function scored higher 
by ~0.5 standard deviations (p = 0.037, SE = 0.23), and for 𝜀3/𝜀4 heterozygotes where 
visuospatial ability scores were lower (p = 0.046, SE = 0.14). These did not survive correction 
for multiple testing. Regional African population differences were observed at the APOE 
locus. Marginally, significant associations between APOE genotype, and executive function 
and visuospatial ability indicate the need for larger studies to better examine these 
associations in African populations. Furthermore, longitudinal data could shed light on 
APOE genetic association with rate of change, or decline, in cognitive function.
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INTRODUCTION
Studies conducted in different populations (mostly of European 
ancestry) have reported associations between apolipoprotein E 
(APOE) 𝜀4 and various detrimental outcomes. These include 
susceptibility to, and severity of cardiovascular diseases, HIV 
infection and its associated comorbidities, late onset Alzheimer’s 
disease, and recently COVID-19 (Hendrie et  al., 1995; Savitz 
et  al., 2006; Burt et  al., 2008; Chang et  al., 2011; Panos et  al., 
2013; Kotze et  al., 2015; O’Donoghue et  al., 2018; Kuo et  al., 
2020). Aside from its well-known involvement in disease 
pathogenesis, there is interest in understanding the role of 
APOE variation in normal cognitive function throughout lifespan. 
This is especially true as studies begin to identify associations 
across the globe in heterogeneous populations (Kotze et  al., 
2015). Furthermore, cognition is a complex multifactorial trait 
and studies examining normal cognitive ageing and brain 
morphology have observed associations with APOE (Small 
et  al., 2004; Wisdom et  al., 2011; Rebeck, 2017; O’Donoghue 
et  al., 2018; Hays et  al., 2019; Reas et  al., 2019). These results 
have, however, been inconsistent, and larger meta-analyses have 
observed small, significant differences in cognitive performance 
and brain morphology in European populations between 
𝜀4-carriers and non-𝜀4-carriers (Small et  al., 2004; Wisdom 
et  al., 2011; O’Donoghue et  al., 2018). Studies focused on 
Alzheimer’s disease (AD) have shown that the presence of 𝜀4 
is associated not only with increased susceptibility to AD, from 
2-fold to 33-fold depending on the number of risk alleles and 
ethnicity, but also with an earlier age of onset of the disease 
(Wisdom et  al., 2011; Liu et  al., 2013; Wendelken et  al., 2016; 
Rebeck, 2017). It has also been found to be  associated with 
other neurocognitive phenotypes, including mild cognitive 
impairment (MCI), HIV-associated neurocognitive disorder 
(HAND), brain atrophy and structural pathologies, and the 
pace of age-related cognitive decline (Burt et  al., 2008; Chang 
et  al., 2015; Hendrie et  al., 2015; Wendelken et  al., 2016; 
Lipnicki et  al., 2017; Espinosa et  al., 2018; O’Donoghue et  al., 
2018; Reas et  al., 2019). However, the results of these 
studies  were  mixed, as were the strengths of associations and 
effects for different ethnic groups (Wisdom et  al., 2011;  
Panos et  al., 2013; Lipnicki et  al., 2019; Reas et  al., 2019). 
This may be  due to differences in study design, sample size, 
characterisation and collection of cognition data, and genetic 
diversity due to differences in ethnicity.
The APOE alleles 𝜀2, 𝜀3, and 𝜀4 encode structurally different 
protein isoforms with variable molecule-binding affinity (Corbo 
and Scacchp, 1999). APOE is involved in lipid metabolism, 
specifically of cholesterol, and is integral to cholesterol transport 
and clearance within the central nervous system (Rebeck, 2017). 
Global variation in APOE allele frequencies have been reported 
185 between ethnic groups (Corbo and Scacchp, 1999; Demarchi 
et al. 2005; Singh et al., 2006. The 𝜀3 allele is the most common 
allele across all populations, and 𝜀4 frequencies are higher in 
African and aboriginal populations than in Europeans and 
Asians (Sandholzer et al. 1995; Corbo and Scacchp, 1999; Singh 
et  al., 2006; Liu et  al., 2013). Despite this, evidence for its 
association with AD and other neurocognitive phenotypes in 
populations of African ancestry is either lacking, or very weak 
(Osuntokun et  al., 1995; Willis et  al., 2003; Gureje et  al., 2006; 
Chen et  al., 2010; Liu et  al., 2013; Morgan et  al., 2013; Chang 
et  al., 2015; Hendrie et  al., 2015).
Genomic studies of cognitive function among Africans are 
limited by small sample sizes and low transferability of cognitive 
performance tests to regions where access to formal education 
and lower levels of literacy may affect reproducibility of results 
observed in largely European cohorts (Savitz et  al., 2006; 
Humphreys et  al., 2017; Kobayashi et  al., 2019; Farrell et  al., 
2020). The Health and Aging in Africa: A Longitudinal Study 
of an INDEPTH Community in South  Africa (HAALSI) was 
established to assess trends in sociodemographic determinants, 
morbidity, and mortality associated with population greying 
and the current epidemiological and behavioural transition 
underway in South  Africa (SA) (Gómez-Olivé et  al., 2018; 
Houle et  al., 2019). Cognitive performance data were captured 
for over 5,000 individuals aged 40 years and older from rural 
communities in Bushbuckridge, Mpumalanga, SA, a region 
known to have a high prevalence of HIV (Gómez-Olivé et  al., 
2018; Asiimwe et al., 2020; Rosenberg et al., 2020). Two screening 
tools were used to capture cognitive function: (1) a culturally 
adapted version of the United  States Health and Retirement 
Study (US HRS) screening tool translated into the local language 
Shangaan and (2) the tablet-based Oxford Cognition Screen 
(OCS-Plus), which was adapted and validated in this study 
population (Humphreys et  al., 2017; Gómez-Olivé et  al., 2018; 
Kobayashi et al., 2019; Farrell et al., 2020). It provides domain-
specific scores for cognitive function in episodic memory, 
executive function, language, and visuospatial ability without 
bias to levels of literacy or numeracy (Humphreys et  al., 2017; 
Kobayashi et  al., 2019; Farrell et  al., 2020). Here, a subset 
(n = 1776) of the larger HAALSI cohort was genotyped for the 
APOE locus. Our aim was to examine the associations of APOE 
with total cognition score and specific cognitive domains 
adjusting for known moderators, such as age, level of education 
Abbreviations: AA, African American; AD, Alzheimer’s Disease; APOE, 
Apolipoprotein E Gene; AFR, 1,000 Genomes African super population group; 
AMR, 1,000 Genomes Admixed American super population group; AWI-Gen, 
Africa Wits-INDEPTH Partnership for Genomic Studies; CVDs, Cardiovascular 
Diseases; EAS, 1,000 Genomes East Asian super population group; EUR, 1,000 
Genomes European super population group; GRCh37, Genome Reference 
Consortium Human genome build 37; HAALSI, The Health and Aging in Africa: 
A Longitudinal Study of an INDEPTH Community in South  Africa; HAND, 
HIV-Associated Neurocognitive Disorder; HIV, Human Immunodeficiency Virus; 
HWE, Hardy Weinberg Equilibrium; LOAD, Late-onset Alzheimer’s Disease; MCI, 
Mild Cognitive Impairment; OCS-Plus, Oxford Cognition Screen Plus; SAS, 1,000 
Genomes South Asian super population group; SBIMB, Sydney Brenner Institute 
for Molecular Bioscience; SNPs, Single-nucleotide polymorphisms; US HRS, United 
States Health and Retirement Study.
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and sex. HIV status was also included as a covariate, and 
we  sought to explore a possible relationship between HIV 
status and APOE in this cohort.
MATERIALS AND METHODS
Study Design and Participants
Demographic, socioeconomic, health and cognitive function 
data were collected from 5,059 adults (men and women, aged 
40 years and older) recruited from Bushbuckridge, rural 
Mpumalanga, South Africa, from November 2014 to November 
2015, as the baseline for the HAALSI longitudinal study (Gómez-
Olivé et  al., 2018). African participants who had been living 
in the area for at least 12 months preceding data collection 
were selected from the Health and Demographic Surveillance 
System database and consented (Kahn et  al., 2012). Cognitive 
function variables: HIV status, age, sex, and educational attainment 
expressed as level of education (none, primary, high and tertiary) 
were used in this population-based cross-sectional community 
study. Sample size differed per outcome due to missing data. 
Approximately 2000 of these same participants overlapped with 
the Africa Wits-INDEPTH Partnership for Genomic Studies 
(AWI-Gen) for which blood samples were collected for DNA 
extraction and genetic analyses (Ramsay et  al., 2016; Ali et  al., 
2018). Data collection and informed consent templates for the 
HAALSI and AWI-Gen studies were approved by the University 
of the Witwatersrand, Johannesburg, Human Research Ethics 
Committee [Wits HREC (Medical); M141159, M121029], the 
Harvard T.H. Chan School of Public Health, Office of Human 
Research Administration (C13-1608-02), and the Mpumalanga 
Provincial Research and Ethics Committee (approved: 2014/10/22). 
Ethics approval for this study was independently granted by 
Wits HREC (Medical) (M170916).
Cognition Screening Tools and Data
Two different tools were utilised to collect data on cognitive 
function (Gómez-Olivé et  al., 2018; Kobayashi et  al., 2019; 
Farrell et  al., 2020). The first tool was adapted from the US 
HRS cognition screening tool. It was translated into the local 
language, Shangaan, and then back-translated to ensure cultural 
appropriateness and transferability (Kobayashi et  al., 2019; 
Farrell et al., 2020). It included questions assessing the following 
measures: orientation, immediate and delayed word recall, 
numeracy, self-rated memory, and literacy (Gómez-Olivé et al., 
2018; Kobayashi et  al., 2019; Farrell et  al., 2020). A score 
from 0 to 24, defined here as, ‘total cognition score’, representing 
global cognition, was used as one outcome variable for this 
study. The OCS-Plus was developed and then validated in a 
subset of HAALSI participants to capture cognitive domain-
specific data without literacy or numeracy bias (Humphreys 
et  al., 2017). Episodic memory, language, executive 
function, and visuospatial cognition data were collected and 
transformed into z-scores for each individual per domain thus 
providing standardised domain-specific scores for this population 
using methods described by Seidlecki et al. (2008)  
(Farrell et al., 2020). The sample size was larger for total 
cognition score than for the domain outcomes.
DNA Extraction and APOE Genotyping
DNA was extracted from buffy coat samples using the 
QIAsymphony SP (QIAGEN GmbH, QIAGEN Strasse 1, 40,724 
Hilden, Germany) at the Sydney Brenner Institute for Molecular 
Bioscience (SBIMB). TaqMan™ single-nucleotide polymorphism 
(SNP) genotyping was performed using DNA from 1952 
individuals for rs429358 and rs7412, of which 1776 were 
successfully genotyped at both loci. Genotyping was performed 
on the QuantStudio™ 5 Real-Time PCR System (Applied 
Biosystems, Thermo Fisher Scientific, Carlsbad, United  States), 
and results were analysed using the QuantStudio™ Design & 
Analysis Software. APOE alleles were determined by using the 
genotypes for the SNPs rs429358 (T, C) and rs7412 (C, T). 
When the combined haplotype was TT, this represented the 
ε2 allele. When the haplotype was TC ε3, and when the 
haplotype was CC this was interpreted as ε4.
SNP data for 2,504 individuals from the 1000 Genomes 
Project (Phase 3) were downloaded from the Ensembl genome 
browser for the Genome Reference Consortium Human Genome 
build 37 (GRCh37; ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/
phase3/data; Accessed 11 Feb, 2021; Auton et  al., 2015; 1,000 
Genomes Project and AWS, RRID:SCR_008801). Samples were 
divided according to super population codes as representative 
of European (EUR), African (AFR), East Asian (EAS), South 
Asian (SAS), and Admixed American (AMR) ancestries (Auton 
et al., 2015; 1,000 Genomes Project and AWS, RRID:SCR_008801). 
APOE alleles were determined as above, and frequencies for 
each of these super populations were compared to our data.
Statistical Analysis
Allele and genotype frequencies were calculated, and Hardy-
Weinberg equilibrium (HWE) was tested using the Pearson’s 
Chi-squared test. Chi-squared tests were used to test for differences 
in APOE allele distribution and categorical measures of age, 
sex, level of education, HIV status, each of the 1,000 Genomes 
super populations and data from four previous African studies 
(Willis et  al., 2003; Gureje et  al., 2006; Chen et  al., 2010 and 
Joska et  al., 2010). The allele frequency data are represented 
as pie diagrams on the backdrop of a map of Africa created 
by MapChart1 (2021). In order to assess correlations between 
APOE distribution and age, age was categorised firstly as 10-year 
intervals, and then as younger (40–59 years) vs. older (60 years 
and older). Descriptive statistics was used to summarise 
continuous (age, total cognition score and domain-specific 
z-scores) and categorical variables (HIV status, level of education). 
Two-sample hypothesis testing was used to further tease out 
the observed association between APOE and HIV. This was 
followed by logistic regression to determine the effects of each 
allele on HIV status while adjusting for the presence or absence 
of one of the other alleles. Cognitive function, either as total 
cognition score or as one of the four above-mentioned domains, 
1 https://mapchart.net/africa.html
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were used as outcome variables to test for associations. Linear 
regression models for each cognitive outcome were tested. Four 
models were tested as follows: (1) regression using six known 
genotypes (2) regression comparing 𝜀3 homozygotes to 𝜀4-carriers 
(3) regression comparing 𝜀4 homozygotes to the rest of the 
genotypes and (4) regression comparing 𝜀2 homozygotes to 
𝜀4 homozygotes. Chi-squared tests, two-sample proportion testing 
and logistic regression analysis reporting McFadden’s R2 were 
performed using STATA 15.0.585 (StataCorp, 2017; Stata Statistical 
Software: Release 15, College Station, TX: StataCorp LLC; Stata, 
RRID:SCR_012763), and summary statistics, regression analyses 
and correction for multiple testing were performed using R 
(R Core Team, 2020. R: A language and environment for 
statistical computing; R Foundation for Statistical Computing, 
Vienna, Austria. https://www.R-project.org/; R Project for 
Statistical Computing, RRID:SCR_001905). Bonferroni correction 
was applied for multiple testing.
RESULTS
The phenotypic characteristics and covariates of the study 
population along with the number of participants (n) with 
data for each variable are shown in Table  1. The mean age 
was 56.19 years, and there were more female participants 
(58.22%). Education levels in the community were low with 
the majority having no formal education or having only attended 
primary school (74.66%). HIV infection was high with 28.48% 
of the study population living with HIV. Total cognition score 
was normally distributed with a mean of 11.98. The four 
standardised domain scores showed considerable variability. 
The range was particularly wide for visuospatial cognition 
(−10.627 to 4.771) and executive function (−4.687 to 4.328).
In total, 1776 individuals were successfully genotyped, and 
all six genotypes were observed with 𝜀2 homozygotes having 
the lowest frequency (2.9%) and 𝜀3/𝜀3 the highest (34.9%; 
Table  2). The genotype distribution was in Hardy Weinberg 
equilibrium (p = 0.28). Our sample had a similar allele frequency 
distribution to that of the AFR super population group of 
Phase 3 of the 1,000 Genomes Project (χ2 = 1.0983, df = 2, 
p = 0.35; Figure  1). The frequencies of 𝜀2 and 𝜀4 were higher 
in our sample than in the other populations (EUR, EAS, SAS 
and AMR representing South American ethnicities). When 
compared to other African studies (Figure  2), a significant 
difference in allele frequency distribution was observed between 
our data and that of Chen et  al. (2010) in a study from Kenya 
(χ2 = 11.058, df = 2, p = 0.004), but due to the small sample size, 
this difference may not be  true.
APOE allele distribution showed no correlation with sex 
(χ2 = 1.3329, df = 2, p = 0.514) or level of education (χ2 = 5.7393, 
df = 6, p = 0.453). No significant difference in allele frequency 
was observed between age categories per decade nor for younger 
vs. older individuals (χ2 = 2.0264, df = 6, p = 0.917, and χ2 = 0.4175, 
df = 2, p = 0.812, respectively). There was evidence of a relationship 
between HIV status and APOE allele frequency (χ2 = 6.9266, 
df = 2, p = 0.031). Results of hypothesis testing indicated that 
the proportion of ɛ3 alleles was higher in HIV individuals 
than in those without HIV (p = 0.001) and the opposite was 
observed for ɛ4 (p = 0.007). Logistic regression results showed 
the size and direction of the effects of each allele on HIV 
status, but these associations were not significant as our model 
had little predictive value (McFadden’s pseudo R2 = 0.0023; 
Table  3).
Four multiple regression models were applied, to allow for 
comparative analyses with other studies, to each of the five 
cognitive phenotypes. Each model was representative of the 
comparison between APOE genotypes (Model 1: all genotypes; 
Model 2: 𝜀3 homozygotes vs. 𝜀4-carriers; Model 3: 𝜀4 
homozygotes vs. the rest of the genotypes; and Model 4: 𝜀2 
homozygotes vs. 𝜀4 homozygotes) and their effect on cognition 
while adjusting for covariates (age, sex, level of education and 
HIV status). Age and level of education were significantly 
associated with cognitive function in all of the models, and 
sex was significant for executive function, language and 
visuospatial cognition for models 1–3 where being male increased 
TABLE 1 | Summary characteristics of study population.
Measure n Range Mean or 
percentage
SD




Level of education 1772








Total cognition score 1776 0 to 24 11.98 4.44
Cognitive domains 1502
Executive function −4.687 to 4.328
Episodic memory −3.824 to 1.456
Language −2.533 to 1.279
Visuospatial cognition −10.627 to 4.771
Sample number (n) differs per covariate/measure due to data missingness. Z-scores for 
cognitive domain data are represented only as ranges. Means and standard deviation 
(SD) are shown for continuous variables and percentages for categorical ones.
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FIGURE 1 | Comparison of APOE allele distribution in our data set (Study data) compared to 1,000 Genomes super population data sets AFR, EUR, EAS, SAS and 
AMR. Pearson’s Chi-squared test was used to assess differences in APOE allele frequency between sample populations from each of the 1,000 Genomes super 
populations and our study sample.
FIGURE 2 | Comparison of APOE allele frequency distributions from four African studies, showing sample size for each study. Pearson’s Chi-squared test was 
used to assess differences in APOE allele frequency between sample populations from each of the African studies referenced by the country of origin/description: 
Uganda: Willis et al., 2003; Nigeria: Gureje et al., 2006; Kenya: Chen et al., 2010; SA neonates: Joska et al., 2010.
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the standard estimates for each domain (Table  4 and 
Supplementary Table S1). Significant associations were observed 
in Model 1 (Table  4) for APOE genotypes, where 𝜀2/𝜀2 was 
associated with higher levels of executive function by 
approximately half a standard deviation (β = 0.489, SE = 0.57, 
p = 0.037) and lower levels (but not significantly) when 
participants were heterozygous 𝜀2-carriers, and 𝜀3/𝜀4 was 
associated with lower levels of visuospatial cognition (β = −0.286, 
SE = 0.14, p = 0.046). These effects (f2 = 0.395 and f2 = 0.597, 
respectively) were not significant after Bonferroni correction 
for multiple testing (p = 0.337 and 0.416, respectively).
DISCUSSION
This cross-sectional study assessed the potential effect of APOE 
genetic variation on five measures of cognition in a rural-
dwelling SA population. Participants were adults of African 
ethnicity aged 40 years and older. We  aimed to address the 
lack of African data for large cohorts that can be  used to 
examine the genetics of cognition and cognitive decline, 
specifically in rural areas where vulnerability to cognitive 
impairment and dementia is becoming a major public health 
concern (Kobayashi et  al., 2019). Association studies have 
observed genetic variation in neurocognitive traits between 
different ethnicities (Savitz et  al., 2006; Fitzgerald et  al., 2020). 
Here, we  determined APOE allele frequency distribution for 
our dataset and then compared this to existing data from 
other population groups. The genetic contribution to cognitive 
function is complex, and the tests used to define levels of 
cognition have made equitable comparisons between studies 
difficult (Savitz et al., 2006; Goriounova and Mansvelder, 2019; 
Fitzgerald et  al., 2020). This is especially challenging in a low 
literacy setting despite the development of tests to assess 
cognition regardless of levels of literacy. Nonetheless, both 
literacy and level of education are still associated with cognition 
in this study cohort (Kobayashi et  al., 2019; Farrell et  al., 
2020). Traditionally, intelligence has been measured using the 
intelligence quotient (IQ) or Spearman’s g (used in meta-
analyses), which are biased towards access to formal education 
(as they focus mostly on aspects related to literacy and numeracy) 
(Goriounova and Mansvelder, 2019; Fitzgerald et  al., 2020). 
Here, we focused on latent cognitive ability which encompasses 
domain-specific and global cognitive function outside of 
educational attainment (Goriounova and Mansvelder, 2019; 
Fitzgerald et  al., 2020). Collecting cognition data is further 
complicated by using screening tools which have not been 
validated for transferability across populations; therefore, the 
OCS-Plus tool was developed to provide an alternative method 
for capturing cognition data in low-income populations that 
was neither reliant on literacy nor numeracy (Humphreys et al., 
2017). The HAALSI baseline study provided an appropriate 
setting to validate this tablet-based tool, providing population-
specific cognitive function data for an understudied and socially 
homogeneous population (Humphreys et al., 2017; Gómez-Olivé 
et  al., 2018). Leveraging these data and further capitalising 
on the overlap of AWI-Gen participants for which DNA was 
available, we  sought to explore genetic effects of APOE on 
cognitive function.
APOE genotyping revealed that ɛ2 and ɛ4 are generally more 
common in African populations, including in our own, with 
SA and Uganda having the highest frequencies of ɛ2 among 
African populations (Figure 2). Although these allele frequencies 
differed significantly from the Chen et  al. (2010) cross-sectional 
study of a population in Kenya, the small sample size of this 
Kenyan study was insufficient for accurate comparison of intra-
continental variation of APOE. The higher ɛ4 frequency in 
Africans has been attributed to selective advantage as protection 
against infectious disease (Corbo and Scacchp, 1999; Fujioka 
et  al., 2014; Van Exel et  al., 2017; Smith et  al., 2019). APOE 
ɛ4 has been suggested to be protective against hepatitis C infection 
as well as carriers being observed to have a better prognosis 
post infection (Kuhlmann et al., 2010; Mueller et al., 2016; Smith 
et  al., 2019). There is also evidence that ɛ4 inhibits growth of 
Plasmodium falciparum conveying a protective effect against 
malaria (Fujioka et  al., 2014; Van Exel et  al., 2017; Smith et  al., 
2019). Higher observed ɛ4 frequency in Africans has also been 
attributed to the hypothesis that it is beneficial for fertility and 
early infant survival (Joska et  al., 2010; Van Exel et  al., 2017; 
Smith et al., 2019). Despite these proposed early life advantages, 
it has also been associated with increased morbidity and mortality 
later in life (Hendrie et  al., 1995; Savitz et  al., 2006; Burt et  al., 
2008; Chang et  al., 2011; Panos et  al., 2013; Kotze et  al., 2015; 
Van Exel et  al., 2017; O’Donoghue et  al., 2018; Smith et  al., 
2019; Kuo et al., 2020). Smaller African studies mainly assessing 
APOE association with AD showed no significant associations 
(Willis et  al., 2003; Gureje et  al., 2006; Chen et  al., 2010; 
Joska  et  al., 2010). The genetic associations between ɛ4 and 
neurocognitive phenotypes (mostly AD due to its highly replicated 
association with increased susceptibility) have observed weaker 
effects in those of admixed African ancestry (AA and Brazilians) 
and lack of association in Africans (Osuntokun et  al., 1995; 
Willis et  al., 2003; Small et  al., 2004; Wisdom et  al., 2011; 
Hendrie et al., 2015; O’Donoghue et al., 2018; Gouveia et al., 2019).
Previous epidemiological studies on the HAALSI cohort 
have reported the effects of age, sex, level of education and 
HIV status on these same cognitive phenotypes (Kobayashi 
et  al., 2019; Asiimwe et  al., 2020; Farrell et  al., 2020). Higher 
educational attainment and younger age are known to 
be associated with better cognitive performance, and we observed 
these same education-related effects across all cognitive 
phenotypes in our study and in our regression models. In 
this study population, we  observed better performance in the 
domains of executive function and language in male participants, 
TABLE 3 | APOE allele association with HIV status.
Allele HIV+(n) HIV-(n) OR[95%CI] z p
ℇ2 0.163 (165) 0.166 (421) 0.997 [0.77–1.29] −0.02 0.980
ℇ3 0.612 (618) 0.569 (1443) 1.149 [0.82–1.60] 0.82 0.412
ℇ4 0.225 (227) 0.265 (672) 0.843 [0.66–1.08] −1.37 0.172
Logistic regression was performed to determine size and direction of effects of APOE 
on HIV status.
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a finding that had already been published by Farrell et  al. 
(2020) who attributed this sex difference to socio-cultural 
differences and access to education (Kobayashi et  al., 2019). 
Other studies have suggested that older women generally have 
better cognitive performance than their male counterparts 
possibly due to the effects of oestrogen or differences in cognitive 
reserve (Wu et  al., 2012; Hayat et  al., 2014; Clifford et  al., 
2015; Sundermann et al., 2016; Lipnicki et al., 2019). Sex effects 
appear to be  domain-specific, and this has been observed in 
studies where women performed better in tests assessing memory 
than men irrespective of educational background (Clifford et al., 
2015; Sundermann et  al., 2016).
For this study, we  used HIV status as a covariate because 
of the high prevalence of HIV and its known contribution to 
cognitive impairment through HAND (Andres, 2011; Panos 
et  al., 2013; Chang et  al., 2015; Rebeck, 2017; Geffin and 
McCarthy, 2018; Hulgan et  al., 2018). Upon assessment of the 
APOE distributions for each of the covariates, we  observed 
statistical differences between allele distribution according to 
HIV status. When modelling the effects of each allele on HIV 
status, logistic regression indicated that our model consisting 
of HIV status conditional on APOE allele was inadequate, which 
could be  due to small sample size. Although the proportion 
of ɛ3 alleles was significantly higher in HIV positive individuals, 
the relative effect of this allele on HIV status compared to the 
effects of the other alleles was not significant. This is contrary 
to another SA study reporting lower ɛ3 allele frequency in 
HIV positive adults vs. newborn controls (Joska et  al., 2010). 
The opposite relationship for ɛ4, with a higher proportion 
observed in those without HIV, was also not significant, but 
our results suggested that ɛ3 is the risk allele for HIV infection. 
APOE ɛ4 has been linked to AIDS severity and increased 
mortality especially in ɛ4 homozygotes (Valcour et  al., 2004; 
Burt et  al., 2008; Chang et  al., 2015; Wendelken et  al., 2016). 
It has been associated with faster disease progression and higher 
viral load in seropositive individuals due to enhanced entry of 
the virus into T cells (Burt et  al., 2008; Kuhlmann et al., 2010). 
This may explain why we  see a higher proportion of ɛ3  in 
our HIV positive sample as faster disease progression and poorer 
prognosis may have resulted in earlier HIV-related mortality 
in ɛ4-carriers. The mortality profile of the community from 
which this cohort was recruited was subject to high levels of 
HIV-associated death, and increased all cause death in age 
groups from 15 to 64 years in the years preceding data collection 
for this study (Kabudula et  al., 2014). HIV progression is 
accompanied by domain-specific cognitive deficits characterised 
as HAND, where ɛ4 is associated with reduced performance 
in these domains (Chang et al., 2011; Panos et al., 2013; Chang 
et al., 2015; Wendelken et al., 2016; Geffin and McCarthy, 2018). 
Some studies have failed to replicate these findings and have 
reported either no association between ɛ4 and HIV, or lack of 
association between ɛ4 and HAND (Joska et  al., 2010; Morgan 
et  al., 2013; Becker et  al., 2015; Cysique et  al., 2015). HIV 
status had no significant effect on cognitive function in any 
of our models. This result may be  attributed to widespread 
use of antiretroviral therapy in this community and also an 
indication that people living with HIV may have better access 
to healthcare and thus are better able to manage both age-related 
and HIV-associated morbidity (Kabudula et  al., 2014; Asiimwe 
et  al., 2020; Rosenberg et  al., 2020). There is evidence that 
this sample population may have a high prevalence of HAND 
within the HIV positive group, but further evidence for trends 
in the development of accurately diagnosed HAND and 
seropositivity in the context of APOE have not been explored 
(Asiimwe et  al., 2020; Rosenberg et  al., 2020).
Although we observed possible associations of APOE genetic 
variants with executive function and visuospatial cognition, 
these associations did not survive correction for multiple testing. 
APOE ɛ2 homozygosity was linked to increased executive 
function scores and ɛ3/ɛ4 heterozygosity to lower visuospatial 
performance. Other studies comparing performance on cognition 
tests between ɛ3 homozygotes and ɛ4-carriers observed impaired 
executive function, episodic memory, global cognition and 
processing speed in ɛ4-carriers which was exacerbated in ɛ4 
homozygotes (Lipnicki et  al., 2017; O’Donoghue et  al., 2018; 
Hays et  al., 2019). Replication of these findings has proven 
TABLE 4 | Linear regression model 1 using all genotypes to estimate the effects of APOE and covariates on cognitive function.
Total cognition Executive function Language Memory Visuospatial cognition
Model Coefficient SE Coefficient SE Coefficient SE Coefficient SE Coefficient SE
All genotypes
ℇ3/ℇ4 −0.306 0.24 −0.042 0.10 −0.048 0.04 −0.062 0.06 −0.286* 0.14
ℇ3/ℇ2 −0.134 0.27 0.024 0.11 0.013 0.04 0.021 0.07 −0.063 0.16
ℇ2/ℇ4 −0.107 0.35 −0.025 0.15 −0.015 0.05 0.066 0.09 −0.060 0.22
ℇ4/ℇ4 0.114 0.39 −0.066 0.16 −0.058 0.06 −0.036 0.09 −0.164 0.24
ℇ2/ℇ2 0.434 0.57 0.489* 0.23 0.155 0.09 0.099 0.14 0.470 0.35
Age −0.093*** 0.01 −0.037*** <0.01 −0.013*** <0.01 −0.029*** <0.01 −0.081*** 0.01
Male −0.018 0.19 0.264* 0.08 0.059* 0.03 −0.05 0.05 0.383* 0.12
Education 1.758*** 0.12 0.823*** 0.05 0.355*** 0.02 0.349*** 0.03 1.394*** 0.07
HIV positive 0.017 0.21 −0.004 0.09 −0.025 0.03 −0.041 0.05 −0.175 0.13
Adjusted 
R-squared
0.221 3.91 0.283 1.48 0.325 0.54 0.245 0.87 0.374 2.20
Standardised coefficients represent estimated changes in cognitive function. Domain estimates (executive function, language, memory and visuospatial cognition) change in 
standard deviation units. Adjusted R-squared values per model with residual standard error (SE) are shown. p < 0.5; *p < 0.00001; ***p < 2e-16.
Soo et al.   APOE and Cognition in SA
Frontiers in Genetics | www.frontiersin.org 8 October 2021 | Volume 12 | Article 689756
challenging (Savitz et  al., 2006; O’Donoghue et  al., 2018; 
Fitzgerald et al., 2020). We observed an increase of ~0.5 standard 
deviations in the domain of executive function for ɛ2/ɛ2 
individuals and ~ 0.3 standard deviations reduction in visuospatial 
ability of ɛ3/ɛ4 individuals, larger effects than those of a large 
meta-analysis by Small et  al. (2004). They observed reduced 
performance of <0.1 standard deviations for global cognition, 
episodic memory and executive function in ɛ4 carriers, with 
significantly poorer cognitive performance associated with ɛ4 
homozygosity (Small et  al., 2004). A later meta-analysis of 77 
studies totalling 40,942 individuals observed similar results 
when assessing the effects of APOE on normal cognitive function 
(Wisdom et  al., 2011). Contrary to the findings of Wisdom 
et  al. (2011), we  did not observe significantly higher memory 
scores in ɛ2 homozygotes compared to ɛ4 homozygotes.
We report on baseline genetic and domain-specific cognitive 
function data for a large African study cohort. However, sample 
size was a limitation for observing small genetic effects for 
associations between APOE genotypes and cognitive function. 
Meta-analyses have estimated the effect sizes of APOE on 
different cognitive domains to vary between approximately 0.07 
and 0.002 (Small et  al., 2004; Wisdom et  al., 2011). But to 
detect the effect size of 0.01 estimated by Wisdom et al. (2011) 
for visuospatial ability, we  would need to double our sample 
size. Our models explained modest variation of cognitive function 
mostly due to highly significant associations observed with age 
(cognition score decreasing with increasing age) and level of 
education (cognition score increasing as higher levels of education 
are achieved), which are known to influence normal cognitive 
function. It has been suggested that cognition changes throughout 
the lifespan and that ɛ4-carriers perform better at cognition 
tests when they are younger due to antagonistic pleiotropy 
and the compensation of other pathways which improve cognition 
and cognitive reserve at younger ages, but become detrimental 
over the age of 60 years (Chang et  al., 2011; Panos et  al., 2013; 
Rebeck, 2017; O’Donoghue et  al., 2018). We  were unable to 
confirm this in our study, but longitudinal data from HAALSI’s 
second wave of data collection will enable the assessment of 
the effects of APOE on age-related cognitive decline.
There is little data on cognitive function and domain-specific 
genetic associations in African populations. Research in European 
and Asian populations has shown that APOE genetic variation 
is associated with cognition and differences in susceptibility 
to several diseases. Despite previous associations between ɛ4 
and cognition, we  were unable to replicate these findings. 
Instead, we observed a trend towards higher executive function 
in ɛ2 homozygotes and lower visuospatial cognition in ɛ3/ɛ4 
heterozygotes. These associations were strongly moderated by 
education and age, and there was minimal indication for the 
independent influence of APOE on latent cognitive function. 
Cognition screening tools which are culturally adapted and 
unbiased in terms of literacy and numeracy are essential for 
the accurate interpretation of cognition in populations with 
low levels of education. The inconclusive results of this study 
may further catalyse African exploratory studies of the complex 
genetics behind cognition, and the role of known environmental 
confounders that are becoming increasingly important in the 
prediction, prevention, and treatment of dementia in low- to 
middle-income countries.
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